Skip to main content
PW Medtech Group Limited logo

PW Medtech Group Limited — Investor Relations & Filings

Ticker · 1358 ISIN · KYG7306W1087 LEI · 894500L18EYHNJR6VJ41 HKEX Manufacturing
Open in API
Filings indexed 784 across all filing types
Latest filing 2020-12-30 Capital/Financing Update
Country KY Cayman Islands
Listing HKEX 1358

About PW Medtech Group Limited

http://www.pwmedtech.com

PW Medtech Group Limited is a medical device company engaged in the research, development, production, and sale of advanced infusion therapy products. The company's core portfolio includes specialized infusion sets and related accessories, such as non-PVC and DEHP-free infusion systems, precision filter infusion sets, light-resistant infusion sets, and safety IV catheters. Operating primarily in China, India, the Americas, and Africa, the Group emphasizes patient and clinician safety. Key innovations include positive pressure needleless connectors designed to prevent blood backflow and contamination, and safety-engineered devices utilizing double-layer tubing (TPU/PVC) and high-precision filtration to mitigate needlestick injuries and adverse infusion reactions.

Recent filings

Filing Released Lang Actions
VERY SUBSTANTIAL DISPOSAL - CLOSINGS OF THE CITIC DISPOSAL AND THE MANAGEMENT DISPOSAL II
Capital/Financing Update Classification · 95% confidence The document is an announcement from PW Medtech Group Limited regarding the closing of disposals related to CITIC and Management Disposal II. It references previous announcements, circulars, and poll results, and provides updates on the status of these transactions and expected future announcements. The content focuses on transaction closings and related corporate actions rather than presenting financial statements or detailed financial data. The document length is 4236 characters, which is relatively short and typical for an announcement rather than a full report. There is no indication of it being a full Annual Report, Interim Report, or Earnings Release. It is not a proxy solicitation, voting results, or management change announcement. The document is best classified as a Capital/Financing Update (CAP) because it deals with disposals and related corporate financing transactions.
2020-12-30 English
FURTHER CHANGE OF BOOK CLOSURE PERIOD AND PAYMENT DATE OF THE SPECIAL DIVIDEND
Notice of Dividend Amount Classification · 95% confidence The document is an announcement from PW Medtech Group Limited regarding changes to the book closure period and payment date of a special dividend. It references previous announcements and circulars but primarily focuses on updating shareholders about dividend-related dates and procedures. The document is relatively short (3866 characters) and does not contain financial statements or detailed financial analysis. It is not a full report but an announcement about dividend payment details. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2020-12-29 English
CHANGE OF BOOK CLOSURE PERIOD AND PAYMENT DATE OF THE SPECIAL DIVIDEND
Notice of Dividend Amount Classification · 95% confidence The document is an announcement from PW Medtech Group Limited regarding a change in the book closure period and payment date of a special dividend. It references previous announcements and shareholder approvals related to the special dividend and disposals. The content focuses on dividend payment details, record dates, and shareholder entitlements. There are no financial statements, detailed financial performance data, or comprehensive report content. The document is relatively short (3929 characters) and serves as an official announcement about dividend timing changes rather than the dividend report itself. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2020-12-14 English
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON DECEMBER 8, 2020 AND PAYMENT OF THE SPECIAL DIVIDEND
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement from PW Medtech Group Limited regarding the poll results of an Extraordinary General Meeting (EGM) held on December 8, 2020. It details the approval of resolutions including the payment of a Special Dividend. The text includes voting results, dividend payment details, and references to prior circulars and notices related to the EGM. There are no financial statements or detailed financial analysis present, only the official results of shareholder voting and dividend declaration. This matches the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA). The document length is 8038 characters, which is sufficient for a detailed voting result announcement rather than a brief notice. Therefore, the correct classification is DVA with high confidence.
2020-12-08 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2020
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30/11/2020, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content focuses on share capital changes and securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting monthly share capital movements to the exchange, typical of a regulatory compliance disclosure rather than a financial report or announcement of voting results. The document is lengthy (15,000 characters) and contains detailed data, not a brief announcement or certification. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories like Share Issue/Capital Change (SHA) because it is a monthly return report rather than a single capital change event.
2020-12-03 English
UNAUDITED RESULTS FOR THE THIRD QUARTER OF 2020 OF CHINA BIOLOGIC PRODUCTS HOLDINGS, INC.
Earnings Release Classification · 90% confidence The document is an announcement by PW Medtech Group Limited regarding the unaudited financial results of its associate, China Biologic Products Holdings, Inc. (CBPO), for the third quarter of 2020. It references an earnings release filed with the SEC and provides a summary of key financial figures from that earnings release. The document is relatively short (4195 characters) and primarily serves to inform shareholders and investors about the earnings release of an associate company, rather than presenting a full financial report of PW Medtech itself. It does not contain comprehensive financial statements or detailed analysis typical of an Interim/Quarterly Report (IR). Instead, it is an announcement of an earnings release, which aligns with the definition of an Earnings Release (ER) as an initial announcement of quarterly financial results with key highlights. Therefore, the appropriate classification is Earnings Release (ER). Q3 2020
2020-11-25 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.